Santen
Buying intent
43 tracked signals | Top 15 topics are below | Finance and Sales are carrying most of it.
Attention by team
LinkedIn activity, by teamWhere Santen's own people are actually spending their attention, by team, by topic. Bands run Low to High against the busiest pairing on this page, and each cell also shows how much of that team's own activity it represents.
Topics being researched
30-day windowEvery tracked topic, ranked by volume, not by our guess at what matters. Confidence is the classifier's own certainty that a signal belongs where we've filed it.
3d ago
4d ago
4d ago
10d ago
19d ago
10d ago
17d ago
3d ago
30d ago
25d ago
19d ago
17d ago
5d ago
27d ago
30d ago
Need intent for a specific topic or industry?
We track the full taxonomy across every account in the graph — including themes not shown on this page.
Who's active at Santen
verified title on fileTitles, seniority and topic straight from each person's own activity, with a LinkedIn link so you can check any of them yourself.
See everyone, not just the first 10
11 people across every department at Santen, plus a LinkedIn profile link for each.
Primary products / business lines
LinkedIn company profileAs a specialized company dedicated to ophthalmology, Santen carries out research, development, marketing, and sales of pharmaceuticals, over-the-counter products, and medical devices. Santen is the market leader for prescription ophthalmic pharmaceuticals in Japan and its products now reach patients in over 60 countries and regions. With scientific knowledge and organizational capabilities nurture
Top accounts researching Santen
names withheld on the public pageThese are companies whose own people brought up Santen unprompted, not accounts we guessed might be interested. We can't yet tell an implementation partner from a genuine buyer here, names unlock along with the buyer profile below.
1,191 companies · 3,711 people are researching Finance Transformation
Santen's own team shows 4 signals on this topic. No one outside Santen has been seen researching the company by name yet — so this is the market it sits in, not a list of its buyers.
- Hiring66,174 cos · 318,882 people
- Social Media17,638 cos · 65,198 people
Buyer profile
company size · seniorityCompany size and how senior the people involved are, the two things that decide whether this is a real deal. Competitor overlap isn't computed yet for this account.
Buying committee functions
Employee job titles (LinkedIn)Sales — 2 people; Finance — 1 person; Leadership — 1 person; Marketing — 1 person
What's been said
public posts mentioning SantenUp to 9 public excerpts naming Santen from the past 365 days, across LinkedIn, Reddit, X, YouTube and other public sources.
A few days attending the Association for Research in Vision and Ophthalmology (ARVO) 2026 Annual Meeting in Denver reinforced the strong momentum across ophthalmology, and the importance of staying closely connected to the science shaping what’s next. Across partnering discussions where we exchanged insights and reviewed progress across ongoing clinical programs, one theme stood out to me: the pace of innovation in ophthalmology continues to accelerate. Connecting with global KOLs and academic leaders further reinforced this, offering valuable perspective on emerging modalities and the real-world needs that continue to guide our work. At Santen , our focus remains on advancing care in ways that make a measurable difference for patients. Collaboration across the field is critical to turning scientific progress into meaningful improvements in care. #ARVO26 #SantenProud #HappinessWithVision
May 2026There’s a great spirit of collaboration and openness here in Copenhagen, exactly what’s needed to drive meaningful progress in our industry. It’s inspiring to be part of an event where ideas are shared so freely, and where innovation, technology, and purpose come together. This is more than just a gathering; it’s a real opportunity to help shape the future of pharma through collective insight, forward-thinking discussions, and the growing role of AI in improving patient outcomes. Proud to be part of a community that’s building with vision and intention. #ISPE #ISPE2026 #ISPEEUROPE #Santen #AI #HappinessWithVision
Apr 2026